MarketCap
Facebook
X
Telegram
Sleep Number Corporation Financial Ratios 2026-2009 | SNBR
Brief overview of Sleep Number Corporation's valuation and returns
This overview follows the five latest available observations from 2017 through 2022.
Market valuation is represented by P/E 23.61x (median 18.19x), EV/EBITDA 139.4x (median 16.67x), P/S 0.1x (median 0.41x). On average, this basket is 29.8% above its own five-year medians. The market is pricing in elevated future expectations.
At the current P/E, inverse earnings yield is 4.2%, a useful bridge between price and business earnings.
Returns on assets and capital are represented by ROE 22.8%, ROA -19.4%, ROCE 8.1%. Negative returns point to losses or poor capital efficiency. Valuation multiples are less informative in this setting.
PEG of 0.45x shows valuation is not outpacing embedded growth. The conclusion depends on earnings durability.
The cash cycle changed only slightly and ended at -9.3 days.
Valuation takeaway
Sleep Number Corporation combines weak profitability with valuation above its historical norm, leaving limited cushion.
Annual Financial Ratios Sleep Number Corporation
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -8.2 | -22.0 | 23.6 | 13.1 | - | 18.2 | 17.9 | 25.5 | 21.5 | 24.4 | - | 15.2 | 16.3 | 17.4 | 46.6 | - |
P/S |
- | 0.1 | 0.2 | 0.4 | 1.0 | - | 0.9 | 0.8 | 1.1 | 0.9 | 1.4 | - | 1.0 | 1.4 | 0.9 | - | - |
EPS |
-5.8 | -0.9 | -0.7 | 1.6 | 5.0 | - | 2.8 | 2.0 | 1.6 | 1.1 | 1.3 | - | 1.1 | 1.4 | 1.1 | 0.8 | - |
EV (Enterprise Value) |
1.26 B | 1.48 B | 1.73 B | 2.25 B | 2.84 B | - | 2.45 B | 1.82 B | 2.04 B | 1.35 B | 1.82 B | - | 1.01 B | 1.33 B | 544 M | 477 M | -11 M |
EBITDA per Share |
0.39 | 3.95 | 4.32 | 6.04 | 8.91 | - | 5.9 | 4.38 | 3.72 | 2.39 | 2.65 | - | 2.21 | 2.53 | 1.24 | 0.78 | - |
EV/EBITDA |
139.4 | 16.5 | 17.8 | 16.7 | 11.4 | - | 9.9 | 9.3 | 10.9 | 8.7 | 11.3 | - | 7.0 | 8.5 | 7.1 | 13.3 | - |
PEG |
- | - | - | - | - | - | 0.45 | 0.74 | 0.65 | -0.95 | 1.48 | - | -0.72 | 0.67 | -0.67 | - | - |
P/B |
- | -0.4 | -0.8 | -2.0 | -8.1 | - | -9.3 | -11.4 | 18.6 | 4.9 | 6.4 | - | 4.1 | 6.6 | 9.5 | - | - |
P/CF |
- | 6.1 | -37.3 | 23.9 | 6.5 | - | 11.5 | 14.5 | 14.7 | 48.6 | 24.4 | - | 80.9 | 26.0 | 8.6 | 7.7 | - |
ROE % |
22.82 | 4.50 | 3.46 | -8.35 | -62.14 | - | -51.34 | -63.48 | 72.99 | 22.72 | 26.46 | - | 26.69 | 40.32 | 54.48 | 46.70 | - |
ROA % |
-19.41 | -2.36 | -1.61 | 3.84 | 17.40 | - | 10.15 | 14.79 | 13.79 | 10.09 | 14.33 | - | 15.74 | 22.84 | 18.59 | - | - |
ROCE % |
8.05 | -5.06 | -5.19 | -15.49 | -82.55 | - | 53.06 | -498.80 | 55.56 | 27.21 | 35.43 | - | 37.08 | 57.35 | 71.68 | 74.72 | - |
Current Ratio |
0.5 | 0.7 | 0.7 | 0.7 | 0.8 | - | 0.3 | 0.3 | 0.5 | 0.8 | 1.2 | - | 1.4 | 1.6 | 1.2 | - | - |
DSO |
2.0 | 4.8 | 5.1 | 5.0 | 3.1 | - | 9.4 | 5.9 | 4.9 | 13.3 | 6.2 | - | 5.7 | 6.5 | 6.0 | - | - |
DIO |
25.9 | 58.7 | 52.4 | 39.1 | 21.2 | - | 49.2 | 51.3 | 56.2 | 66.8 | 43.4 | - | 40.9 | 38.4 | 31.5 | - | - |
DPO |
37.2 | 65.4 | 71.3 | 53.7 | 23.9 | - | 76.0 | 87.5 | 86.2 | 80.2 | 68.3 | - | 74.8 | 73.0 | 67.4 | - | - |
Operating Cycle |
27.9 | 63.5 | 57.5 | 44.1 | 24.3 | - | 58.5 | 57.2 | 61.1 | 80.2 | 49.6 | - | 46.6 | 44.9 | 37.4 | - | - |
Cash Conversion Cycle |
-9.3 | -1.9 | -13.8 | -9.6 | 0.4 | - | -17.5 | -30.3 | -25.1 | -0.1 | -18.7 | - | -28.1 | -28.1 | -30.0 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sleep Number Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.19 | -1.73 | -1.09 | -0.38 | - | -0.14 | -0.22 | -0.33 | - | -0.1 | 0.03 | 0.51 | - | 0.23 | 1.56 | 0.09 | - | 2.29 | 0.91 | 2.63 | - | 1.83 | -0.45 | 1.4 | - | 0.96 | 0.14 | 0.83 | - | 0.53 | 0.1 | 0.54 | - | 0.63 | -0.02 | 0.57 | - | 0.56 | 0.03 | 0.27 | - | 0.63 | 0.21 | 0.55 | - | 0.44 | 0.16 | 0.31 | - | 0.37 | 0.18 | 0.43 | - | 0.47 | 0.3 | 0.4 | - | 0.31 | 0.21 | 0.3 |
EBITDA per Share |
-1.06 | - | - | 0.73 | - | - | - | 1.02 | - | - | - | 1.98 | - | 2.79 | 3.66 | 0.89 | - | 5.01 | 2.44 | 3.59 | - | 4.14 | 0.67 | 2.45 | 1.18 | 2.94 | 1.29 | 1.58 | 1.23 | 2.1 | 0.92 | 1.11 | 0.52 | 2.09 | 0.67 | 1.22 | 0.35 | 1.79 | 0.65 | 0.7 | 0.53 | 1.55 | 0.75 | 1.04 | - | 1.22 | 0.6 | 0.65 | 0.18 | 0.96 | 0.53 | 0.76 | 0.35 | 0.99 | 0.63 | 0.69 | 0.35 | 0.66 | 0.44 | 0.54 |
ROE % |
22.76 | 15.43 | 8.92 | 5.40 | 3.51 | 4.06 | 3.18 | -0.65 | -2.33 | -3.48 | -11.91 | -12.18 | -9.48 | -21.69 | -26.05 | -38.19 | -37.75 | -87.66 | -67.70 | -87.30 | -67.27 | -82.38 | -50.06 | -60.50 | -51.34 | -60.86 | -59.93 | -60.66 | -63.48 | -21.13 | 24.25 | 26.80 | 72.99 | 62.32 | 49.66 | 51.42 | 32.07 | 32.41 | 28.06 | 31.50 | 34.07 | 36.15 | 28.08 | 31.08 | 20.42 | 23.27 | 22.81 | 23.58 | 26.68 | 30.27 | 34.81 | 39.17 | 40.32 | 45.75 | 45.54 | 45.50 | 46.74 | 13.32 | 8.72 | 12.82 |
ROA % |
-17.30 | -9.81 | -5.08 | -2.79 | -1.76 | -2.00 | -1.56 | 0.20 | 1.03 | 1.56 | 5.48 | 5.63 | 4.44 | 10.52 | 12.59 | 17.02 | 16.79 | 23.37 | 15.64 | 16.90 | 8.80 | 11.79 | 8.69 | 10.86 | 10.15 | 12.91 | 13.31 | 13.57 | 14.79 | 12.40 | 13.94 | 12.98 | 13.79 | 12.91 | 13.12 | 13.59 | 11.25 | 12.77 | 12.77 | 14.78 | 17.79 | 18.76 | 15.31 | 17.31 | 11.46 | 13.15 | 13.49 | 13.91 | 15.74 | 17.71 | 20.06 | 22.43 | 22.83 | 25.03 | 23.93 | 23.27 | 23.03 | 6.56 | 4.30 | 6.31 |
ROCE % |
13.23 | 5.46 | -3.64 | -4.90 | -4.49 | -5.77 | -6.57 | -11.30 | -10.06 | -12.95 | -22.94 | -21.20 | -15.10 | -31.63 | -36.10 | -47.81 | -46.87 | -114.57 | -90.60 | -117.11 | -94.14 | -114.83 | -71.69 | -83.67 | -70.31 | -84.41 | -82.97 | -80.33 | -84.37 | -27.01 | 39.88 | 38.35 | 103.09 | 90.08 | 70.66 | 75.58 | 47.81 | 49.11 | 41.46 | 46.47 | 50.24 | 53.58 | 42.34 | 46.94 | 30.77 | 35.05 | 34.49 | 35.74 | 40.27 | 46.00 | 53.14 | 59.78 | 54.34 | 51.92 | 49.45 | 48.28 | 58.48 | 18.30 | 12.17 | 20.40 |
Current Ratio |
0.5 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 | - | 0.9 | 0.8 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 1.2 | 1.2 | 1.2 | 1.2 | 1.5 | 1.5 | 1.5 | 1.5 | 2.2 | 1.9 | 2.2 | 2.2 | - | 2.1 | 2.5 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.3 | 2.3 | 2.3 | 2.3 | 2.0 | 2.0 | 2.0 | - |
DSO |
3.9 | 4.0 | 4.2 | 3.7 | - | 4.0 | 4.7 | 4.7 | - | 4.1 | 4.7 | 4.3 | - | 4.7 | 4.4 | 4.9 | - | 4.0 | 4.6 | 2.1 | - | 4.2 | 3.7 | 2.6 | 4.1 | 3.8 | 5.1 | 4.8 | 5.5 | 5.5 | 7.2 | 5.2 | 4.8 | 4.4 | 6.2 | 4.5 | 5.7 | 4.9 | 6.5 | 5.1 | 6.5 | 5.7 | 6.4 | 2.3 | - | 6.1 | 5.8 | 5.0 | 5.9 | 5.2 | 6.6 | 5.6 | 6.9 | 6.1 | 7.4 | 5.3 | 6.7 | 6.3 | 7.8 | - |
DIO |
57.1 | 62.8 | 69.1 | 61.9 | - | 51.6 | 53.8 | 50.8 | - | 53.8 | 55.9 | 48.7 | - | 45.1 | 45.7 | 37.5 | - | 31.9 | 40.7 | 17.7 | - | 38.4 | 61.2 | 45.3 | - | 44.5 | 57.2 | 47.8 | - | 47.1 | 60.8 | 51.1 | - | 51.6 | 71.2 | 49.3 | - | 50.5 | 64.8 | 40.8 | - | 47.5 | 54.2 | 19.1 | - | 33.6 | 43.3 | 36.8 | - | 37.7 | 48.2 | 36.4 | - | 37.7 | 44.1 | 28.1 | - | 30.7 | 38.5 | - |
DPO |
75.8 | 72.4 | 76.7 | 66.3 | - | 63.9 | 63.2 | 61.3 | - | 72.7 | 73.3 | 71.0 | - | 70.4 | 70.1 | 54.6 | - | 53.6 | 60.0 | 26.2 | - | 61.0 | 85.3 | 71.6 | - | 68.8 | 88.5 | 77.6 | - | 80.4 | 103.7 | 82.7 | - | 79.0 | 109.1 | 72.6 | - | 70.9 | 91.0 | 60.1 | - | 66.1 | 73.2 | 27.3 | - | 53.0 | 60.6 | 59.4 | - | 68.8 | 88.1 | 67.9 | - | 71.8 | 83.9 | 54.8 | - | 62.0 | 77.6 | - |
Operating Cycle |
- | 66.8 | 73.3 | 65.5 | - | 55.6 | 58.5 | 55.5 | - | 57.9 | 60.6 | 53.0 | - | 49.8 | 50.1 | 42.3 | - | 35.9 | 45.4 | 19.8 | - | 42.5 | 64.9 | 47.9 | 4.1 | 48.4 | 62.4 | 52.6 | 5.5 | 52.6 | 67.9 | 56.2 | 4.8 | 55.9 | 77.4 | 53.8 | 5.7 | 55.4 | 71.3 | 45.9 | 6.5 | 53.2 | 60.5 | 21.4 | - | 39.7 | 49.1 | 41.9 | 5.9 | 42.9 | 54.8 | 42.0 | 6.9 | 43.8 | 51.5 | 33.4 | 6.7 | 37.0 | 46.3 | - |
Cash Conversion Cycle |
- | -5.6 | -3.3 | -0.8 | - | -8.3 | -4.8 | -5.8 | - | -14.8 | -12.7 | -18.0 | - | -20.6 | -20.0 | -12.2 | - | -17.7 | -14.7 | -6.5 | - | -18.4 | -20.4 | -23.7 | 4.1 | -20.5 | -26.1 | -25.1 | 5.5 | -27.8 | -35.7 | -26.4 | 4.8 | -23.1 | -31.7 | -18.8 | 5.7 | -15.5 | -19.7 | -14.2 | 6.5 | -12.9 | -12.7 | -5.9 | - | -13.3 | -11.5 | -17.6 | 5.9 | -26.0 | -33.3 | -25.9 | 6.9 | -27.9 | -32.4 | -21.4 | 6.7 | -24.9 | -31.3 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Sleep Number Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Italia
